GlassScriptPhysician profile
David Lee Spivey
NPI 1275510570
$2,056.72
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $231 · 2021: $417 · 2022: $515 · 2023: $97.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $458.78 | 2021-2022 | |
| Abbott Laboratories | $417.24 | 2019-2023 | Proclaim |
| Medtronic USA, INC. | $320.80 | 2019-2020 | |
| Boston Scientific Corporation | $130.46 | 2019-2022 | |
| Pfizer INC. | $117.51 | 2019 | |
| Collegium Pharmaceutical, INC. | $88.49 | 2019-2023 | Xtampza |
| Daiichi Sankyo INC. | $67.63 | 2019 | |
| Sentynl Therapeutics, INC. | $60.55 | 2019 | |
| Mdd US Operations, LLC | $51.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.77 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.12 | 2022-2023 | Relistor |
| Zyla Life Sciences, INC. | $40.71 | 2019-2020 | |
| Forte Bio-Pharma LLC | $32.48 | 2020-2021 | |
| Vertos Medical, INC. | $27.54 | 2020 | |
| Virtus Pharmaceuticals LLC | $26.68 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $25.39 | 2019 | |
| Si-Bone, INC. | $23.50 | 2023 | |
| Nalu Medical, INC. | $19.21 | 2021 | |
| Depuy Synthes Sales INC. | $14.50 | 2019 | |
| Shionogi INC | $14.03 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.05 | 2020 | |
| Biodelivery Sciences International, INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.